Like what you read? Get new posts delivered straight to your inbox!
Contact Us | Follow Us
Experience. Integrity. IMPACT.
What We Do

Ilana Dew, PhD Promoted to Senior Clinical Research Scientist

RESEARCH TRIANGLE PARK, NC: 20 April 2017 – In April 2017, Ilana Dew, PhD was promoted to the position of Senior Clinical Research Scientist at Impact Pharmaceutical Services, Inc. (IMPACT).

Since joining the IMPACT family in June of 2016, Ilana has made significant contributions to IMPACT’s growth and the development of our corporate culture. In the role of Senior Clinical Research Scientist, Ilana provides a variety of services for IMPACT’s clients, including authoring various types of regulatory documents (eg, meeting requests, briefing documents, study protocols, components of marketing applications [NDAs/MAAs], and clinical study reports) across many different therapeutic areas. In addition to providing high-quality drug development services to IMPACT’s clients, Ilana serves as an active member of the company’s ‘Making an IMPACT’ community outreach initiative.

“Ilana came to IMPACT with a breadth of experience from her previous 3 years at a fast-paced CRO,” said Tim Garver, IMPACT Executive Vice President and COO. “Since her arrival here at IMPACT, Ilana has leveraged that experience to consistently provide our clients with high-quality regulatory documents and project management expertise. Her sense of enthusiasm for any new project makes it a true pleasure to work with Ilana.”

“Ilana has been a key part of the growth and development of our corporate culture,” said Nancy Smith, IMPACT Senior Manager. “She has provided innovative approaches to mentoring and training our newer employees and truly understands the needs of a growing CRO. Ilana embodies the spirit of teamwork we foster at IMPACT and sets a great example for our clinical research scientists early in their careers.”

IMPACT is a Contract Research Organization (CRO) located in Research Triangle Park, NC. Our team consists of drug development professionals who specialize in medical writing and quality control, drug development consulting, regulatory affairs, regulatory operations, project and program management, and early phase clinical trial management.

Media Contact:

Mark A. Cierpial, PhD, Chief Executive Officer
Phone: (919) 899-9248
Fax: (919) 354-6090